CRH Medical Corp (NASDAQ:CRHM) has been downgraded to Sector Perform in a report by RBC Capital Markets today.
- Updated: November 28, 2016
Boasting a price of $5.65, CRH Medical Corp (NASDAQ:CRHM) traded -14.52% lower on the day. With the last close up 33.03% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.03% over the date range. CRH Medical Corp has recorded a 50-day average of $4.98 and a two hundred day average of $3.98. Trading volume was up over the average, with 488,400 shares of CRHM changing hands over the typical 87,023
RBC Capital Markets has downgraded CRH Medical Corp (NASDAQ:CRHM) to Sector Perform in a statement released on 11/28/2016.
With a total market value of $0, CRH Medical Corp has with a one year low of $2.15 and a one year high of $6.30 .
Brief Synopsis About CRH Medical Corp (NASDAQ:CRHM)
CRH Medical Corporation, formerly Medsurge Medical Products Corp., is a healthcare products and services company. The Company operates through segments, including the sale of medical products and the provision of anesthesia services. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology. The Company also provides anesthesiology services to gastroenterologists in the southeastern United States through its subsidiaries. The Company's product distribution strategy focuses on physician education, patient outcomes, and patient awareness. The Company's first product, the CRH O'Regan System, is a single use, disposable, hemorrhoid banding technology for treating hemorrhoid grades I – IV. It principally operates in the United States. It distributes the CRH O'Regan System to physicians. The Company's subsidiary, Gastroenterology Anesthesia Associates, LLC, provides anesthesiology services for gastroenterology procedures.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.